Literature DB >> 23314697

The role of microRNAs in B-cell development and function.

Jingyi Li1, Ying Wan, Qing Ji, Yongfei Fang, Yuzhang Wu.   

Abstract

MicroRNA (miRNA)-mediated gene silencing at the translational level has led to novel discoveries for numerous biological processes. Recently, there has been increasing evidence to indicate that miRNAs are involved in normal immune functions and inflammation. In this review, we focus on recent advances that have elucidated the role of miRNAs in B-cell development, differentiation, apoptosis and function. While the regulatory mechanisms of miRNAs in controlling and maintaining B-cell fate remain largely uncharacterized, further studies on miRNAs and their targets will increase our understanding of B-cell development and function. Such studies may be able to provide new therapeutic strategies for treating autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23314697      PMCID: PMC4003047          DOI: 10.1038/cmi.2012.62

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  42 in total

1.  High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma.

Authors:  Anke van den Berg; Bart-Jan Kroesen; Klaas Kooistra; Debora de Jong; Jane Briggs; Tjasso Blokzijl; Susan Jacobs; Joost Kluiver; Arjan Diepstra; Ewerton Maggio; Sibrand Poppema
Journal:  Genes Chromosomes Cancer       Date:  2003-05       Impact factor: 5.006

2.  T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC.

Authors:  Deanna Haasch; Yung-Wu Chen; Regina M Reilly; X Grace Chiou; Sandra Koterski; Morey L Smith; Paul Kroeger; Kerri McWeeny; Donald N Halbert; Karl W Mollison; Stevan W Djuric; James M Trevillyan
Journal:  Cell Immunol       Date:  2002 May-Jun       Impact factor: 4.868

3.  High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma.

Authors:  Markus Metzler; Monika Wilda; Kerstin Busch; Susanne Viehmann; Arndt Borkhardt
Journal:  Genes Chromosomes Cancer       Date:  2004-02       Impact factor: 5.006

Review 4.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

5.  MicroRNAs regulate B-cell receptor signaling-induced apoptosis.

Authors:  J L Kluiver; C-Z Chen
Journal:  Genes Immun       Date:  2012-02-23       Impact factor: 2.676

6.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

7.  B-cell regulator of immunoglobulin heavy-chain transcription (Bright)/ARID3a is a direct target of the oncomir microRNA-125b in progenitor B-cells.

Authors:  M P Puissegur; R Eichner; C Quelen; E Coyaud; B Mari; K Lebrigand; C Broccardo; F Nguyen-Khac; M Bousquet; P Brousset
Journal:  Leukemia       Date:  2012-04-03       Impact factor: 11.528

8.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

9.  Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus.

Authors:  Yao Yuan; Siddha Kasar; Chingiz Underbayev; Daniel Vollenweider; Erica Salerno; Sergei V Kotenko; Elizabeth Raveche
Journal:  Mol Immunol       Date:  2012-05-11       Impact factor: 4.407

10.  Silencing of microRNA-21 in vivo ameliorates autoimmune splenomegaly in lupus mice.

Authors:  Barry G Garchow; Oscar Bartulos Encinas; Yiu Tak Leung; Patricia Y Tsao; Robert A Eisenberg; Roberto Caricchio; Susanna Obad; Andreas Petri; Sakari Kauppinen; Marianthi Kiriakidou
Journal:  EMBO Mol Med       Date:  2011-09-01       Impact factor: 12.137

View more
  16 in total

1.  Frontiers in B-cell immunology.

Authors:  Liwei Lu
Journal:  Cell Mol Immunol       Date:  2012-12-24       Impact factor: 11.530

Review 2.  MicroRNAs as regulatory elements in immune system logic.

Authors:  Arnav Mehta; David Baltimore
Journal:  Nat Rev Immunol       Date:  2016-04-28       Impact factor: 53.106

Review 3.  Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL).

Authors:  Krystyna Mazan-Mamczarz; Ronald B Gartenhaus
Journal:  Leuk Res       Date:  2013-09-07       Impact factor: 3.156

4.  17β-Estradiol and 17α-Ethinyl Estradiol Exhibit Immunologic and Epigenetic Regulatory Effects in NZB/WF1 Female Mice.

Authors:  Rujuan Dai; Michael R Edwards; Bettina Heid; S Ansar Ahmed
Journal:  Endocrinology       Date:  2019-01-01       Impact factor: 4.736

5.  miR-182 is largely dispensable for adaptive immunity: lack of correlation between expression and function.

Authors:  Joseph N Pucella; Wei-Feng Yen; Myoungjoo V Kim; Joris van der Veeken; Chong T Luo; Nicholas D Socci; Yukiko Naito; Ming O Li; Naoharu Iwai; Jayanta Chaudhuri
Journal:  J Immunol       Date:  2015-02-11       Impact factor: 5.422

Review 6.  MicroRNAs as Regulators of Phagocytosis.

Authors:  Wojciech Gierlikowski; Barbara Gierlikowska
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

7.  Human Staufen1 associates to miRNAs involved in neuronal cell differentiation and is required for correct dendritic formation.

Authors:  Joan Peredo; Patricia Villacé; Juan Ortín; Susana de Lucas
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

8.  The modulation of Dicer regulates tumor immunogenicity in melanoma.

Authors:  Nicholas C Hoffend; William J Magner; Thomas B Tomasi
Journal:  Oncotarget       Date:  2016-07-26

9.  MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production.

Authors:  Yingting Mok; Vera Schwierzeck; David C Thomas; Elena Vigorito; Tim F Rayner; Lorna B Jarvis; Haydn M Prosser; Allan Bradley; David R Withers; Inga-Lill Mårtensson; Lynn M Corcoran; Cherie Blenkiron; Eric A Miska; Paul A Lyons; Kenneth G C Smith
Journal:  J Immunol       Date:  2013-08-19       Impact factor: 5.422

10.  Decreased production of class-switched antibodies in neonatal B cells is associated with increased expression of miR-181b.

Authors:  Stephanie Glaesener; Christine Jaenke; Anika Habener; Robert Geffers; Petra Hagendorff; Katrin Witzlau; Esther Imelmann; Andreas Krueger; Almut Meyer-Bahlburg
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.